Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Dec 2022	37	Global Markets Direct	ASDR-613943

Published: Dec 2022 - Pages : 37 - Publisher : Global Markets Direct - Report code : ASDR-613943

Crinetics Pharmaceuticals Inc
Cyclacel Pharmaceuticals Inc
Diurnal Group Plc
Recordati SpA
Strongbridge Biopharma plc